SCHEMBL26669264

SCHEMBL26669264

Cc1nc(Nc2ccc(C(F)(F)F)cn2)ccc1S(N)(=O)=O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ TNNI3K Q59H18 1/20 0.43
▸ POLB P06746 2/20 0.41
▸ XPO1 O14980 1/20 0.41
▸ PTGS1 P23219 1/20 0.40
▸ NPY5R Q15761 1/20 0.40
▸ KIF11 P52732 1/20 0.40
▸ MAPT P10636 2/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ AGTR1 P30556 1/20 0.37
▸ HSD11B1 P28845 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ AR P10275 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29704119 0.84 CA2 (0.45) GAAKDM4ETNNI3KKIF11MAPT
SCHEMBL29704094 0.80 KDM4E (0.54) GAAKDM4ETNNI3KPOLBXPO1
SCHEMBL22718342 0.80 KDM4E (0.54) GAAKDM4ETNNI3KPOLBXPO1
SCHEMBL26669276 0.79 GAA (0.40) GAAKDM4ETNNI3KPOLBXPO1
SCHEMBL28418739 0.77 GAA (0.58) GAAPOLBXPO1PTGS1NPC1
SCHEMBL29704107 0.76 MAPK10 (0.41) GAAKDM4ETNNI3KPOLBXPO1
SCHEMBL29704110 0.76 MAPK10 (0.41) GAAKDM4ETNNI3KPOLBXPO1
SCHEMBL30194891 0.76 PTGES2 (0.54) GAAKDM4ETNNI3KMAPK10NPC1
SCHEMBL26669262 0.76 PTGS2 (0.47) KIF11NPC1RAB9AKMT2A
SCHEMBL29704172 0.75 PDE2A (0.40) KIF11HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281073-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2023-11-29 — — EP disclosed
WO-2022159986-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2022-07-28 — — WO disclosed
Send feedback